siRNA-Mediated MELK Knockdown Induces Accelerated Wound Healing with Increased Collagen Deposition.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
10 Jan 2023
Historique:
received: 09 12 2022
revised: 22 12 2022
accepted: 06 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

Skin wounds remain a significant problem for the healthcare system, affecting the clinical outcome, patients' quality of life, and financial costs. Reduced wound healing times would improve clinical, economic, and social aspects for both patients and the healthcare system. Skin wound healing has been studied for years, but effective therapy that leads to accelerated wound healing remains to be discovered. This study aimed to evaluate the potential of MELK silencing to accelerate wound healing. A vectorless, transient knockdown of the MELK gene using siRNA was performed in a murine skin wound model. The wound size, total collagen, type 3 collagen, vessel size, vessel number, cell proliferation, cell apoptosis, number of mast cells, and immune infiltration by CD45, CD11b, CD45, and CD8a cells were evaluated. We observed that treatment with MELK siRNA leads to significantly faster wound closing associated with increased collagen deposition.

Identifiants

pubmed: 36674843
pii: ijms24021326
doi: 10.3390/ijms24021326
pmc: PMC9861445
pii:
doi:

Substances chimiques

RNA, Small Interfering 0
Collagen 9007-34-5
MELK protein, human EC 2.7.1.-
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Polish Ministry of National Defense
ID : KOSCIUSZKO 1 no.571/2016/DA

Références

Haematologica. 2018 Aug;103(8):1359-1368
pubmed: 29748441
J Tissue Viability. 2019 Nov;28(4):218-222
pubmed: 31542301
Eur Surg Res. 2017;58(1-2):81-94
pubmed: 27974711
Cancer Discov. 2012 Feb;2(2):172-189
pubmed: 22585861
Cell. 2016 Jan 14;164(1-2):293-309
pubmed: 26771497
Diagn Pathol. 2014 Nov 29;9:221
pubmed: 25432701
Bioengineering (Basel). 2021 May 11;8(5):
pubmed: 34064689
J Dent Res. 2010 Mar;89(3):219-29
pubmed: 20139336
An Bras Dermatol. 2016 Sep-Oct;91(5):614-620
pubmed: 27828635
Open Biol. 2020 Sep;10(9):200223
pubmed: 32993416
J Cell Sci. 2011 Mar 15;124(Pt 6):958-68
pubmed: 21378312
Plast Surg Nurs. 2013 Apr-Jun;33(2):98-100
pubmed: 23727727
N Engl J Med. 1991 Jan 3;324(1):1-8
pubmed: 1701519
Adv Clin Chem. 2014;66:79-100
pubmed: 25344986
J Biol Chem. 2020 Jun 12;295(24):8195-8203
pubmed: 32350113
Front Neuroanat. 2020 Nov 09;14:582218
pubmed: 33240048
Sci Rep. 2019 Oct 4;9(1):14293
pubmed: 31586077
Cell Transplant. 2019 Dec;28(1_suppl):37S-50S
pubmed: 31813279
Biol Trace Elem Res. 2019 Sep;191(1):167-176
pubmed: 30552609
J Tissue Eng Regen Med. 2019 Jan;13(1):99-109
pubmed: 30445662
Adv Wound Care (New Rochelle). 2012 Oct;1(5):218-223
pubmed: 24527309
Cell Mol Life Sci. 2016 Oct;73(20):3861-85
pubmed: 27180275
Cell. 2015 Dec 3;163(6):1515-26
pubmed: 26627737
J Invest Dermatol. 2007 Mar;127(3):514-25
pubmed: 17299434
Sci Signal. 2020 Sep 08;13(648):
pubmed: 32900881
Elife. 2018 Feb 08;7:
pubmed: 29417930
Elife. 2017 Mar 24;6:
pubmed: 28337968
Biomech Model Mechanobiol. 2016 Jun;15(3):663-81
pubmed: 26264498
J Invest Dermatol. 2011 May;131(5):1037-44
pubmed: 21248764
Br J Community Nurs. 2012 Mar;Suppl:S17-8, S20, S22
pubmed: 22584180
J Biomed Biotechnol. 2006;2006(4):63675
pubmed: 17057365
Signal Transduct Target Ther. 2020 Jun 19;5(1):101
pubmed: 32561705
Cell Rep. 2017 Dec 5;21(10):2829-2841
pubmed: 29212029
Elife. 2014 May 20;3:e01763
pubmed: 24844244
Methods Mol Biol. 2022;2434:355-370
pubmed: 35213031

Auteurs

Lukasz Szymanski (L)

Department of Molecular Biology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, 05-552 Magdalenka, Poland.

Sławomir Lewicki (S)

Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, 03-411 Warsaw, Poland.
Faculty of Medical Sciences and Health Sciences, Kazimierz Pulaski University of Technology and Humanities, 26-600 Radom, Poland.

Tomasz Markiewicz (T)

Department of Patomorphology, Military Institute of Medicine, 01-755 Warsaw, Poland.
Faculty of Electrical Engineering, Warsaw University of Technology, 00-662 Warsaw, Poland.

Szczepan Cierniak (S)

Department of Patomorphology, Military Institute of Medicine, 01-755 Warsaw, Poland.

Jean-Pierre Tassan (JP)

UMR 6290, CNRS, Institute of Genetics and Development of Rennes, Dynamics and Mechanics of Epithelia Group, Faculty of Medicine, University Rennes, CEDEX, 35043 Rennes, France.

Jacek Z Kubiak (JZ)

UMR 6290, CNRS, Institute of Genetics and Development of Rennes, Dynamics and Mechanics of Epithelia Group, Faculty of Medicine, University Rennes, CEDEX, 35043 Rennes, France.
Laboratory of Molecular Oncology and Innovative Therapies, Department of Oncology, Military Institute of Medicine, 01-755 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH